EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria
about
Rheumatoid arthritis treatment: the earlier the better to prevent joint damageCharacterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvementsRandomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data.Ultrasound-detectable grey scale synovitis predicts future fulfilment of the 2010 ACR/EULAR RA classification criteria in patients with new-onset undifferentiated arthritisRheumatoid arthritis: erosion defined: back to basics.Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexatePrognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice: A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving a Treat-to-Target StrategyPerformance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review.Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: An expert consensus.Evaluating processes underlying the predictive value of baseline erosions for future radiological damage in early rheumatoid arthritis.The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study.Long-term outcome of rheumatoid arthritis defined according to the 2010-classification criteria.Hypomethylation of CYP2E1 and DUSP22 promoters associated with disease activity and erosive disease among rheumatoid arthritis patients.Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies.Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications.Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice.Deleterious role of hepatitis B virus infection in therapeutic response among patients with rheumatoid arthritis in a clinical practice setting: a case-control study.The specificity of ultrasound-detected bone erosions for rheumatoid arthritisPresence of hepatitis B virus in synovium and its clinical significance in rheumatoid arthritis.Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort.The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
P2860
Q26777903-448FE1DD-FA1C-4828-8476-B6AE0D5B592FQ26800693-547A1F87-85F6-4676-ABF6-25F815CC3BC7Q30812918-FD58B01C-012F-4B90-A580-ED2AED18E4EEQ31104875-84D95140-D0E6-405F-8694-A57F6759CD3BQ33552821-11C56492-EAA3-430C-AB6B-C0B50EE8AB4EQ34075064-DF773509-F4C5-4264-95B4-3CF51AF77034Q36027446-DCC75430-7219-4801-BE03-46AFF1EACBDFQ37206416-68E25BF4-BCDF-4329-942B-E3DBAB20279BQ38099628-C5E7120D-EAF7-44F1-8396-4DE64DEF4EA8Q38711954-36C87645-A6DA-4974-B14F-5A1315688620Q39271219-400F83E5-6D36-45F8-8B68-B9BA6A5ED236Q41228105-1DAD84DE-BC68-4F4E-8CA3-F9D8F6D07541Q43523546-FCA23315-9459-4718-A966-BDC6EC3AEEC0Q47183251-6AB1E980-FD11-4F89-B148-8C38CAD23288Q47193354-70251FE8-E17E-47E6-AB25-B165C7D54F8AQ47800990-624610D4-06B0-442B-963A-B082A550D053Q48517263-AF940D2F-C120-42AA-86B6-21913D73CE94Q54222708-B257AE9E-1ED2-4526-9C6C-9678783DA560Q54800246-7E464C14-2BE3-410E-8A39-B27375FA855CQ55379977-C26C5677-BB7C-48A9-9B25-B1EBA2C388F2Q55512246-8B79BB37-0D83-4D9F-B3E5-2EA3ED5F564EQ55689191-37661B36-528B-44E1-8FB2-8C7BDBD32819
P2860
EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
EULAR definition of erosive di ...... hritis classification criteria
@ast
EULAR definition of erosive di ...... hritis classification criteria
@en
EULAR definition of erosive di ...... hritis classification criteria
@en-gb
EULAR definition of erosive di ...... hritis classification criteria
@nl
type
label
EULAR definition of erosive di ...... hritis classification criteria
@ast
EULAR definition of erosive di ...... hritis classification criteria
@en
EULAR definition of erosive di ...... hritis classification criteria
@en-gb
EULAR definition of erosive di ...... hritis classification criteria
@nl
prefLabel
EULAR definition of erosive di ...... hritis classification criteria
@ast
EULAR definition of erosive di ...... hritis classification criteria
@en
EULAR definition of erosive di ...... hritis classification criteria
@en-gb
EULAR definition of erosive di ...... hritis classification criteria
@nl
P2093
P50
P3181
P1476
EULAR definition of erosive di ...... hritis classification criteria
@en
P2093
Alan J Silman
Angela Zink
Bernard Combe
Clifton O Bingham
Cédric Lukas
Daniel Aletaha
Ewa Stanislawska-Biernat
Rachel Knevel
Robert B M Landewé
P304
P3181
P356
10.1136/ANNRHEUMDIS-2012-202779
P407
P50
P577
2013-04-01T00:00:00Z
P5875
P6179
1026126977